Identification of βArrestin2 as a corepressor of androgen receptor signaling in prostate cancer

Vijayabaskar Lakshmikanthan, Lin Zou, Jae I. Kim, Allison Michal, Zhongzhen Nie, Nidia C. Messias, Jeffrey L. Benovic, Yehia Daaka

Research output: Contribution to journalArticlepeer-review

66 Scopus citations


Androgen receptor (AR) signaling regulates the development and homeostasis of male reproductive organs, including the prostate. Deregulation of AR and AR coregulators, expression, or activity is involved in the initiation of prostate cancer and contributes to the transition of the disease to hormone-refractory stage. The ubiquitous βArrestin proteins are now recognized as bona fide adapters and signal transducers with target effectors found in both the cytosol and nucleus. Here, we provide evidence that βArrestin2 forms a complex with AR and acts as an AR corepressor in androgen-dependent prostate cancer cells. Accordingly, the forced overexpression of βArrestin2 diminishes, and knockdown of βArrestin2 expression with RNAi increases the androgen-induced prostate-specific antigen (PSA) gene expression. βArrestin2 serves as an adapter, bringing into close proximity the Mdm2 E3 ligase and AR, thereby promoting AR ubiquitylation and degradation. Human prostate tissues evidence an inverse relationship between the expression of βArrestin2 and AR activity: glands that express high levels of βArrestin2 exhibit low expression of PSA, and those glands that express low levels of βArrestin2 evidence elevated PSA levels. We conclude that βArrestin2 acts as a corepressor of AR by serving as a scaffold forMdm2leading to the AR ubiquitylation and degradation.

Original languageEnglish
Pages (from-to)9379-9384
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Issue number23
StatePublished - Jun 9 2009


  • Androgen deprivation therapy
  • Beta-arrestin
  • Mdm2
  • Testosterone
  • Ubiquitin


Dive into the research topics of 'Identification of βArrestin2 as a corepressor of androgen receptor signaling in prostate cancer'. Together they form a unique fingerprint.

Cite this